Connecting Patients to Treatments, Novel Therapies, and Clinical Trials
ODC serves as a partner for biopharma companies to access the large and diverse patient population of Latin America.
Our capabilities and expertise are focused on supporting global clients from the clinical development stage throughout the entire product lifecycle.
We currently have 60 employees providing services across two verticals:
Clinical Development
& CRO Services
Commercialization
& Early Access
MISSION
Provide clinical trial treatment and access for rare and high-complexity patients in Latin America.
PURPOSE
Provide new clinical trial and treatment access opportunities to our patients and deliver our work with Excellence, Innovation, Commitment, Accountability, and Passion
VISION
Develop Pharma business in Latin America and advance our clients’ technologies using our local expertise.
Our Impact in Numbers
500+
Rare Disease Patients Randomized
25+
Sponsors
Phase I/II trials - 35%
Phase III/IV trials - 65%
2.6 months
Drug Dossier Approval
2.2 months
Protocol Dossier Approval
(Rare Disease Averages)
3.3 months
Drug Dossier Approval
3.4 months
Protocol Dossier Approval
(General Averages)
